Anzeige
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent
Dr Amir Khoury Qrce Nov 8 As Sent

Check these out next

Prof. thomas pogge
Prof. thomas pogge
David Chamberlain
BUTM404 Case studies Case study 3 The pharmaceutical ind.docx
BUTM404 Case studies Case study 3 The pharmaceutical ind.docx
humphrieskalyn
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
Nejmeddine Jemaa
TRIPS developing nations
TRIPS developing nations
Avaniendra chakravartty
Pharmaceuticals and HIV/AIDS
Pharmaceuticals and HIV/AIDS
tchykita
Trips agreement / WHO / WTO agreements
Trips agreement / WHO / WTO agreements
NesnalNiraula
Anti-TPP groups and how to respond to some of them
Anti-TPP groups and how to respond to some of them
Bienvenido "Nonoy" Oplas, Jr.
Lisman New Paradigms
Lisman New Paradigms
jalisman
1 von 45

Dr Amir Khoury Qrce Nov 8 As Sent

28. Dec 2008••
Downloaden Sie, um offline zu lesen
Business

4th Technology Commercialization Conference Amman

QRCE
Anzeige
Anzeige
Anzeige

Recomendados

CC
Cszahidhashmi455 Aufrufe•10 Folien
C.Mkis And Mr 3C.Mkis And Mr 3
C.Mkis And Mr 3QRCE672 Aufrufe•10 Folien
Property Right and Pricing Left, Cheaper Medicines LawProperty Right and Pricing Left, Cheaper Medicines Law
Property Right and Pricing Left, Cheaper Medicines LawBienvenido "Nonoy" Oplas, Jr.1.4K Aufrufe•21 Folien
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptxPolitical Legal & Ethical Dilemmas in the Pharmaceutical.pptx
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptxAmrElBahnasawy129 Aufrufe•22 Folien
Crystina Riffel: Pharmaceutical Drug PoliciesCrystina Riffel: Pharmaceutical Drug Policies
Crystina Riffel: Pharmaceutical Drug Policiesmerlyna792 Aufrufe•19 Folien
Health profits before peopleHealth profits before people
Health profits before peopleSuneeta Mohapatra375 Aufrufe•112 Folien

Más contenido relacionado

Similar a Dr Amir Khoury Qrce Nov 8 As Sent(20)

Prof. thomas poggeProf. thomas pogge
Prof. thomas pogge
David Chamberlain•603 Aufrufe
BUTM404 Case studies Case study 3 The pharmaceutical ind.docxBUTM404 Case studies Case study 3 The pharmaceutical ind.docx
BUTM404 Case studies Case study 3 The pharmaceutical ind.docx
humphrieskalyn•4 Aufrufe
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
GSK’S Andrew Witty: Addressing Neglected Tropical Diseases and global health ...
Nejmeddine Jemaa•851 Aufrufe
TRIPS developing nations TRIPS developing nations
TRIPS developing nations
Avaniendra chakravartty •975 Aufrufe
Pharmaceuticals and HIV/AIDSPharmaceuticals and HIV/AIDS
Pharmaceuticals and HIV/AIDS
tchykita•592 Aufrufe
Trips agreement / WHO / WTO agreementsTrips agreement / WHO / WTO agreements
Trips agreement / WHO / WTO agreements
NesnalNiraula•304 Aufrufe
Anti-TPP groups and how to respond to some of themAnti-TPP groups and how to respond to some of them
Anti-TPP groups and how to respond to some of them
Bienvenido "Nonoy" Oplas, Jr.•363 Aufrufe
Lisman New ParadigmsLisman New Paradigms
Lisman New Paradigms
jalisman•128 Aufrufe
Development of drugs in public-private partnership (PPP) environmentsDevelopment of drugs in public-private partnership (PPP) environments
Development of drugs in public-private partnership (PPP) environments
pmaugeri•884 Aufrufe
What can we do to ensure that patients have the medicines they need? What can we do to ensure that patients have the medicines they need?
What can we do to ensure that patients have the medicines they need?
FernandoLamata•241 Aufrufe
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
James M. Cooper and Bashar H. Malkawi, The need to relax intellectual propert...
Bashar H. Malkawi•65 Aufrufe
TRIPS Plus agendaTRIPS Plus agenda
TRIPS Plus agenda
Avaniendra chakravartty •372 Aufrufe
Relevance Of WTORelevance Of WTO
Relevance Of WTO
Ashutosh Kumar Jha•1.8K Aufrufe
Pharma PatentingPharma Patenting
Pharma Patenting
Sampat Patnaik•4.5K Aufrufe
Michelle Childs - IP EventMichelle Childs - IP Event
Michelle Childs - IP Event
Gordon Renouf•575 Aufrufe
Aiden hollis hif presentation berkeleyAiden hollis hif presentation berkeley
Aiden hollis hif presentation berkeley
Open Science Summit•357 Aufrufe
More on generic_drugsMore on generic_drugs
More on generic_drugs
anamoralj•554 Aufrufe
FinalFinal
Final
naineshsharma•3.4K Aufrufe
A critique of an argument against patent rights for essential medicines (publ...A critique of an argument against patent rights for essential medicines (publ...
A critique of an argument against patent rights for essential medicines (publ...
J S•104 Aufrufe
Ethics in pharma industryEthics in pharma industry
Ethics in pharma industry
Dr Qureshi•9.7K Aufrufe

Más de QRCE(20)

Concept Evaluation And SelectionConcept Evaluation And Selection
Concept Evaluation And Selection
QRCE•27.9K Aufrufe
Triz Basics -Product Design & DevelopmentTriz Basics -Product Design & Development
Triz Basics -Product Design & Development
QRCE•3K Aufrufe
Triz - Product Design & DevelopmentTriz - Product Design & Development
Triz - Product Design & Development
QRCE•8.2K Aufrufe
Product Design & DevelopmentProduct Design & Development
Product Design & Development
QRCE•2.7K Aufrufe
Product Design & Development - 1Product Design & Development - 1
Product Design & Development - 1
QRCE•91.5K Aufrufe
Pd2Product Design & Development - 2Pd2Product Design & Development - 2
Pd2Product Design & Development - 2
QRCE•633 Aufrufe
J.Promotions Decisons 10J.Promotions Decisons 10
J.Promotions Decisons 10
QRCE•446 Aufrufe
K.Implementation 11K.Implementation 11
K.Implementation 11
QRCE•400 Aufrufe
H.Pricing Decisions 8H.Pricing Decisions 8
H.Pricing Decisions 8
QRCE•357 Aufrufe
I.Channel And Distribution Tactics 9I.Channel And Distribution Tactics 9
I.Channel And Distribution Tactics 9
QRCE•902 Aufrufe
G.Product Decision 7G.Product Decision 7
G.Product Decision 7
QRCE•629 Aufrufe
D.The Marketing Environment And Competitor Analysis 4D.The Marketing Environment And Competitor Analysis 4
D.The Marketing Environment And Competitor Analysis 4
QRCE•1.3K Aufrufe
B.Marketing Planning 2B.Marketing Planning 2
B.Marketing Planning 2
QRCE•461 Aufrufe
Intellectual probabilityIntellectual probability
Intellectual probability
QRCE•852 Aufrufe
Escad & Ce MarkingEscad & Ce Marking
Escad & Ce Marking
QRCE•2K Aufrufe
Industrial Standards QrceIndustrial Standards Qrce
Industrial Standards Qrce
QRCE•1.6K Aufrufe
Knauss Angel InvestingKnauss Angel Investing
Knauss Angel Investing
QRCE•772 Aufrufe
Martin Invention Commercialization Ver 2Martin Invention Commercialization Ver 2
Martin Invention Commercialization Ver 2
QRCE•746 Aufrufe
Martin Tto Best Practices Ver3Martin Tto Best Practices Ver3
Martin Tto Best Practices Ver3
QRCE•737 Aufrufe
Bettaieb Tt Conf AmmanBettaieb Tt Conf Amman
Bettaieb Tt Conf Amman
QRCE•662 Aufrufe
Anzeige

Último(20)

THE MARKETING AGENCY.pdfTHE MARKETING AGENCY.pdf
THE MARKETING AGENCY.pdf
Sourav Sikder•0 Aufrufe
PPCH & PPRCT Pipes manufacturer and ExporterPPCH & PPRCT Pipes manufacturer and Exporter
PPCH & PPRCT Pipes manufacturer and Exporter
ANJNEYTUBESINDIA1•0 Aufrufe
-ISO 45001-2018.pptx-ISO 45001-2018.pptx
-ISO 45001-2018.pptx
yousrazeidan1•0 Aufrufe
Practice of Human Resource Management in Global Group..pdfPractice of Human Resource Management in Global Group..pdf
Practice of Human Resource Management in Global Group..pdf
FaisalIslam32•0 Aufrufe
The 10 Most Empowering Women in Mortgage Industry,2023 (1).pdfThe 10 Most Empowering Women in Mortgage Industry,2023 (1).pdf
The 10 Most Empowering Women in Mortgage Industry,2023 (1).pdf
CIO Look Magazine•0 Aufrufe
single channel vs multi channel communicationsingle channel vs multi channel communication
single channel vs multi channel communication
StevenCruise•0 Aufrufe
WL-JMLB1218.pdfWL-JMLB1218.pdf
WL-JMLB1218.pdf
ssuser6a6a24•0 Aufrufe
ISO 9001-2015 Awareness.pdfISO 9001-2015 Awareness.pdf
ISO 9001-2015 Awareness.pdf
yousrazeidan1•0 Aufrufe
LAMBORGHINI HIRE.pdfLAMBORGHINI HIRE.pdf
LAMBORGHINI HIRE.pdf
Sourav Sikder•0 Aufrufe
ISO 14001-2015 .pptISO 14001-2015 .ppt
ISO 14001-2015 .ppt
yousrazeidan1•0 Aufrufe
There's no time to lose.There's no time to lose.
There's no time to lose.
Jim McNeill•0 Aufrufe
Cryptoknowmics Your Ultimate Source Of Comprehensive Crypto News.pdfCryptoknowmics Your Ultimate Source Of Comprehensive Crypto News.pdf
Cryptoknowmics Your Ultimate Source Of Comprehensive Crypto News.pdf
Manojkumar931671•0 Aufrufe
GuzmanRocio_RiskManagement2.pdfGuzmanRocio_RiskManagement2.pdf
GuzmanRocio_RiskManagement2.pdf
RocioGuzmanPerez•0 Aufrufe
Steve Scalabrini - A Proactive and Driven Individual.pdfSteve Scalabrini - A Proactive and Driven Individual.pdf
Steve Scalabrini - A Proactive and Driven Individual.pdf
Steve Scalabrini•0 Aufrufe
BongoHive-Lean-Canvas-Template.pptxBongoHive-Lean-Canvas-Template.pptx
BongoHive-Lean-Canvas-Template.pptx
ssuser3bbeb5•0 Aufrufe
Chronical Resume.pdfChronical Resume.pdf
Chronical Resume.pdf
eduardoumanzor4•0 Aufrufe
WIRED Consultingx Refinitiv_Making big data work for commodities_1.pdfWIRED Consultingx Refinitiv_Making big data work for commodities_1.pdf
WIRED Consultingx Refinitiv_Making big data work for commodities_1.pdf
Faisal638875•0 Aufrufe
WHAT ARE CHAKRA STONES AND THEIR MEANING.pdfWHAT ARE CHAKRA STONES AND THEIR MEANING.pdf
WHAT ARE CHAKRA STONES AND THEIR MEANING.pdf
Jaipur Beads•0 Aufrufe
Semana 14 A.pdfSemana 14 A.pdf
Semana 14 A.pdf
IvethLorenaMaytaAyla•0 Aufrufe
Bahria Orchard LahoreBahria Orchard Lahore
Bahria Orchard Lahore
AliShaban22•0 Aufrufe

Dr Amir Khoury Qrce Nov 8 As Sent

  1. Queen Rania Center for Entrepreneurship (QRCE) The Fourth Annual Conference on Technology Commercialization Amman , November 12-13, 2008 Dr. Amir H. Khoury www.amirkhoury.com “ Creating a New Intellectual Property Policy Regarding Access to Medicines & Technology Relating Thereto”
  4. IP Regulative Framework Conventional International Patent Régime (CIPR) TRIPS (WTO) TRIPS+ (FTAs; OECD) Unilateral (USTR; 301)
  26. Polar Solutions rejected! ….Where to next? Balanced Solution! Incentive to Innovate Moral & Social Justifications for APM
  45. Thank you! Dr. Amir H. Khoury www.amirkhoury.com
Anzeige